Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
This randomized controlled trial examined the effects of testosterone replacement therapy (TRT) on metabolic parameters in hypogonadal men with type 2 diabetes mellitus (T2DM). The study found that TRT significantly improved insulin sensitivity, reduced HbA1c levels, decreased visceral adiposity, and enhanced lipid profiles, including reductions in total cholesterol and LDL
June 26, 2025
No Comments